Davidson Kempner Partners’s Globus Medical GMED Stock Holding History

Davidson Kempner Partners’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	$11.9M	Buy	+209,339	New	+$13.4M	0.23%	94

Other funds holding GMED

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Nuance Investments Kansas City, Missouri $717M AUM 3.8% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Davidson Kempner Partners's GMED Position: Q1 2023 in Review

Davidson Kempner Partners opened a new position in Globus Medical (GMED) in Q1 2023: 209,339 shares worth $11.9M. The stake represents 0.23% of the portfolio and ranks #94 among its holdings.

390 funds tracked by Wall St. Rank hold GMED as of Q1 2023.

Davidson Kempner Partners held 209,339 shares of Globus Medical worth $11.9M as of Q1 2023.
Globus Medical was a new Davidson Kempner Partners position in Q1 2023.
Globus Medical made up 0.23% of Davidson Kempner Partners's portfolio in Q1 2023, its #94 holding.
390 funds tracked by Wall St. Rank held Globus Medical as of Q1 2023.

Based on Davidson Kempner Partners's 13F filing for Q1 2023, filed 15 May 2023.